Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8715
Evaluation of Amonafide in Advanced Sarcomas
Activated
03-01-1988
Closed
02-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8731
Ifosfamide and Mesna in Malignant Mesothelioma
Activated
03-01-1988
Closed
07-15-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8714
Evaluation of Amonafide in Colorectal Carcinoma
Activated
03-01-1988
Closed
05-01-1989
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8732
Evaluation of Amonafide in Endometrial Carcinoma
Activated
03-01-1988
Closed
03-01-1991
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-8734
Phase ll Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Stomach
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1988
Closed
01-01-1990
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8729
Phase II Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Pancreas
Activated
03-01-1988
Closed
01-01-1990
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
SWOG-8790 (INT-0083) (GOG-133)
A Randomized Trial of Adjuvant Intraperitoneal Recombinant Interferon Alpha-2 in Stage III Ovarian Carcinoma in Patients Who Have No Evidence of Disease After Surgery and Chemotherapy
Research Committee(s)
Gynecologic Cancer
Activated
03-01-1988
Closed
06-15-1999
Closed
Phase
Accrual
20%
SWOG Clinical Trial Number
SWOG-8621
Chemo-Hormonal Therapy of Postmenopausal Receptor-Positive Breast Cancer
Activated
02-01-1988
Closed
08-01-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8728
Evaluation of Didemnin B in Metastatic Adenocarcinoma of the Kidney
Activated
01-01-1988
Closed
02-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8716
Evaluation of Amonafide in Renal Cell Carcinoma
Activated
11-01-1987
Closed
11-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8722
Evaluation of Amonafide in Adenocarcinoma of the Prostate
Activated
11-01-1987
Closed
04-01-1989
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
SWOG-8640
Evaluation of Didemnin-B or Trimetrexate in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix
Activated
10-01-1987
Closed
07-15-1990
Closed
Phase
Accrual
69%
Published
SWOG Clinical Trial Number
SWOG-8721
A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
09-01-1987
Closed
09-01-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8703
Evaluation of Vinblastine and High-Dose Cis-Platinum in the Treatment of Advanced Non-Small Cell Lung Cancer
Activated
09-01-1987
Closed
06-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8625
Weekly Cis-Platinum-Based Induction for Extensive Non-Small Lung Cancer, with Cis-Platinum + VP-16 Consolidation
Activated
09-01-1987
Closed
01-15-1988
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-8704
Neoadjuvant Methotrexate, Cisplatin and Vinblastine (MCV) Followed by Concomitant Cisplatin/Radiotherapy for Unresectable Localized Bladder Cancer Patients
Research Committee(s)
Genitourinary Cancer
Activated
09-01-1987
Closed
08-15-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8605
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8623
A Phase II Trial of Trimetrexate in Untreated Advanced Gastric Carcinoma
Activated
08-15-1987
Closed
01-01-1989
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Trial of Cystectomy Alone Versus Neoadjuvant M-VAC +Cystectomy in Patients with Locally Advanced Bladder Cancer
Research Committee(s)
Genitourinary Cancer
Activated
08-01-1987
Closed
07-01-1998
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8692 (INT-0075)
Therapy In Premenopausal Women with Advanced, ER Positive or PgR Positive Breast Cancer: Surgical Oophorectomy vs. the LH-RH Analog, Zoladex
Research Committee(s)
Breast Cancer
Activated
08-01-1987
Closed
07-15-1995